
Join to View Full Profile
18 E 41st StFl 14New York, NY 10017
Phone+1 305-395-4313
Fax+1 954-840-8254
Dr. Seifan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Alon Seifan, located in New York, is board-certified in Neurology, with a UCNS-subspecialty in Behavioral Neurology & Neuropsychiatry. He completed his neurology residency at the University of Miami and his fellowship in the Division of Aging & Dementia of Columbia University. He currently serves as the Chief Science Officer at HB Biotech and runs his practice, Cognitive Neurology Consultants. Dr. Seifan treats patients of all ages, with any neurological or psychiatric symptom, regardless of diagnosis or insurance. He has contributed significant research publications in his field and has been involved in several clinical trials. His notable prior recognitions include the Leon Levy Neuroscience Fellowship Award and the Community Engagement Award from Weill Cornell Medicine. Dr. Seifan is currently developing a novel, brain-healthy medication for treatment of panic disorder, PTSD and other stress-related conditions that works by restoring the brain's natural energy balance.
Clinical Expertise
- Behavioral neurology / Neuropsychiatry, General neurology
Education & Training
Columbia University Vagelos College of Physicians and SurgeonsBehavioral Neurology, 2012 - 2014
University of Miami/Jackson Health SystemResidency, Neurology, 2009 - 2013
Icahn School of Medicine at Mount SinaiClass of 2008
Certifications & Licensure
NJ State Medical License 2024 - 2027
FL State Medical License 2014 - 2026
NY State Medical License 2012 - 2026- United Council of Neurologic SubspecialtiesBehavioral Neurology & Neuropsychiatry
Awards, Honors, & Recognition
- Leon Levy Neuroscience Fellowship Award Weill Cornell Medicine, 2015
- Community Engagement Award Weill Cornell Center for Translational Sciences, 2015
- NIH T32 Neuroepidemology Training Fellowship Award Columbia University Mailman School of Public Health, 2012-2014
- Join now to see all
Clinical Trials
- An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738) Start of enrollment: 2012 Nov 30
- Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss Start of enrollment: 2014 Feb 28
- Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Study Start of enrollment: 2016 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 23 citationsEfficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Preventative Treatment of Episodic Migraine in Adults.T. Dorosch, Christine A. Ganzer, M. Lin, Alon Seifan
Current Pain and Headache Reports. 2019-09-12 - 10 citationsDetecting Non-cognitive Features of Prodromal Neurodegenerative Diseases.Alon Seifan, Christine A. Ganzer, Krista Ryon, Michael T. Lin, Rahman Mahmudur
Current Aging Science. 2019-01-01 - 69 citationsThe clinical practice of risk reduction for Alzheimer's disease: A precision medicine approachRichard S. Isaacson, Christine A. Ganzer, Hollie Hristov, Katherine Hackett, Emily Caesar
Alzheimer's & Dementia. 2018-12-01
Press Mentions
Dementia-Proof Your DietMarch 7th, 2017
Honeybrains, Neurologist-Run NYC Cafe, Is Serving up Food for Thought in NoLItaNovember 28th, 2016
Leon Levy Fellowship in Neuroscience Renewed for $1.92 MillionJuly 24th, 2015
Grant Support
- Leon Levy Neurosciences Fellowship AwardThe Leon Levy Foundation2014–2015
Research History
- Director of Research, Alzheimer Prevention Clinic, Weill Cornell Medicine2014 - 2016
Professional Memberships
- Member
Other Languages
- Spanish, Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









